World trade organization’s export-oriented compulsory licensing mechanism: Foreseen policy concern for Africa to mitigate the COVID-19 pandemic
Author(s) -
Abbas Muhammad Z
Publication year - 2021
Publication title -
journal of generic medicines: the business journal for the generic medicines sector
Language(s) - English
Resource type - Journals
eISSN - 1741-7090
pISSN - 1741-1343
DOI - 10.1177/17411343211010205
Subject(s) - battle , pandemic , business , covid-19 , international trade , economic growth , indigenous , outbreak , development economics , political science , disease , economics , geography , infectious disease (medical specialty) , medicine , virology , ecology , archaeology , pathology , biology
Africa has a history of grappling with outbreaks and high prevalence of disease. It currently confronts COVID-19 which is escalating because of local community transmission of the disease. Poorly resourced health systems in Africa are ill-prepared for the surging number of COVID-19 cases. This paper emphasizes that in the current battle against COVID-19, policymakers should not lose sight of future policy challenges. COVID-19 vaccine has become available, but patent exclusivities might play a major role in hindering access to it. With little or no indigenous pharmaceutical manufacturing capacity of its own, Africa will almost entirely rely on importing COVID-19 vaccines or treatment from third parties. The World Trade Organization’s (WTO’s) Paragraph 6 System, which relates to export-oriented compulsory licensing, is excessively formal and does not suit a pandemic situation which requires swift action. This paper draws policymakers’ attention of to a high priority policy concern for Africa.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom